awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33330720-E8835CFE-6473-4516-8160-09F2338D5B06
Q33330720-E8835CFE-6473-4516-8160-09F2338D5B06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33330720-E8835CFE-6473-4516-8160-09F2338D5B06
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.
P2860
Q33330720-E8835CFE-6473-4516-8160-09F2338D5B06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33330720-E8835CFE-6473-4516-8160-09F2338D5B06
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
017821bad3ae79582b9a08ff288961276c244a47
P2860
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.